Domestic markets rebound as global geopolitical friction begins fading.

Indian benchmark indices witnessed a sharp recovery on Monday, with the BSE Sensex climbing over 400 points to trade near 82,300 while the NSE Nifty successfully reclaimed the psychological 24,000 level. This bullish momentum primarily stems from reports that Iran has approached the United States with a proposal to reopen the Strait of Hormuz, a move that could significantly de-escalate long-standing regional friction.

Energy Stability Drives Gains

Investors reacted positively to the cooling of West Asian tensions, which led to a noticeable slide in Brent crude prices. For an import-dependent nation like India, falling oil prices function as a direct economic stimulus by reducing the current account deficit and easing domestic inflationary pressure. Market participants noted that global cues remained exceptionally firm, with Wall Street reaching fresh record highs and Asian peers like the Nikkei posting solid gains.

Institutional Activity Shifts

Recent data indicates a change in the behavior of Foreign Institutional Investors (FIIs). After weeks of aggressive selling, these large-scale players have returned as net buyers, injecting much-needed liquidity into the system. This shift in capital flow coincided with a broad-based rally where sectors like IT, Power, and Healthcare led the charge. Sun Pharma emerged as a top gainer, surging over 4% in early deals, while the broader midcap and smallcap indices outperformed the front-line benchmarks by gaining nearly 1.5%.

Historically, Indian markets have shown remarkable resilience during West Asian conflicts, often using periods of "geopolitical de-escalation" to price in domestic economic strengths like robust GST collections and stable industrial output.

Analysts suggest that maintaining the 24,000 level is vital for Nifty to sustain this upward trajectory. Should the diplomatic talks between Washington and Tehran progress further, the index might test the 24,500 resistance zone in the coming sessions.

DISCLIMER: Prameya or Prameya News7 does not endorse the views or recommendations expressed by experts/brokerages in this article. These are solely their opinions.